AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gicla M 40mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Serwina Pharmaceuticals Private Limited

Salt Composition

Gliclazide (40mg) + Metformin (500mg)

Overview Gicla M 40mg/500mg Tablet

Gicla M 40mg/500mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Always take Gicla M with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even if feeling well or experiencing controlled blood sugar; discontinuation without medical guidance risks elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Learn to recognize and treat hypoglycemia promptly; maintain regular meals and carry a readily available fast-acting glucose source like sugary snacks or juice. Alcohol consumption raises hypoglycemia risk and should be limited. Other potential side effects are altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before commencing treatment, as Gicla M may be unsuitable. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may recommend blood tests to track blood cell counts and liver function.

Uses of Gicla M 40mg/500mg Tablet

Diabetes mellitus, type 2

Major Benefits of Gicla M 40mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 40mg/500mg Gicla M Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

Common Side effects of Gicla M 40mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Gicla M 40mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Gicla M 40mg/500mg Tablet should be administered with a meal.

How Gicla M 40mg/500mg Tablet works:

Gliclazide and Metformin, combined at 40mg/500mg in Gicla M tablets, offer dual-action diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gicla M 40mg/500mg Tablet with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Gicla M 40mg/500mg tablets is contraindicated during pregnancy due to established fetal risk. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Gicla M 40mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gicla M 40mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Gicla M 40mg/500mg tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gicla M 40mg/500mg Tablets cautiously, potentially requiring dosage modification. Medical advice is essential. A reduced initial dose is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Gicla M 40mg/500mg Tablet :

Should you forget to take your Gicla M 40mg/500mg Tablet, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Gicla M 40mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gicla M 40mg/500mg Tablet

Gicla M 40mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's unsuitable for type 1 diabetes.
Gicla M 40mg/500mg Tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gicla M 40mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Gicla M 40mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged Gicla M 40mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and gait problems), urinary issues, cognitive changes, and balance difficulties. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gicla M 40mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate-to-severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining alcohol and Gicla M 40mg/500mg tablets is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Gicla M 40mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Gicla M 40mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gicla M 40mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Gicla M 40mg/500mg Tablets can cause lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis) resulting from excessive blood lactic acid. While rare, this side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gicla M 40mg/500mg and seek immediate medical attention.
Prolonged use of Gicla M 40mg/500mg tablets can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gicla M 40mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining alcohol and Gicla M 40mg/500mg tablets is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Gicla M 40mg/500mg Tablet
51
MRP 59
13% off